Log In
BCIQ
Print this Print this
 

OG987SC (NN9927)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionLong-acting oral glucagon-like peptide-1 (GLP-1) analogue
Molecular Target Glucagon-like peptide-1 receptor (GLP-1R) (GLP1R)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today